StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note published on Sunday morning. The firm issued a buy rating on the stock. Trinity Biotech Price Performance NASDAQ:TRIB opened at $1.61 on Friday. Trinity Biotech has a 12-month low of $1.49 and a 12-month high of $5.50. The business […]